The impact of hepatitis B virus infection status on the prevalence of nonalcoholic fatty liver disease: A population-based study
- PMID: 31691993
- DOI: 10.1002/jmv.25621
The impact of hepatitis B virus infection status on the prevalence of nonalcoholic fatty liver disease: A population-based study
Abstract
Background: We aimed to explore the impact of hepatitis B virus (HBV) infection on the prevalence of nonalcoholic fatty liver disease (NAFLD) based on clinical big data.
Methods: Data were collected from the health examination center of the First Affiliated Hospital of Fujian Medical University. Univariate and multivariate analysis were applied to investigate the relationship between HBV and NAFLD.
Results: A total of 14 452 patients were included, with an average age of 43.84 ± 13.03 years. Cases of HBV current infection, past infection, and noninfection were 21 102 110 (14.6%), 90 039 003 (62.3%), and 33 393 339 (23.1%), respectively. The prevalence of NAFLD was significantly lower in the current infection group (29.9%) than in the past infection group (35.8%) and noninfection group (31.9%) (P < .001). After adjusting for age, the prevalence of NAFLD in the current infection group remained the lowest across all of the age groups. Multivariate analysis showed that current infection was at a lower risk of NAFLD (odds ratio [OR] = 0.717, 95% CI: 0.608-0.846), whereas past infection had no effect on NAFLD.
Conclusions: Current HBV infection may lower the risk of NAFLD. This effect becomes insignificant when the patient is no longer infected.
Keywords: hepatitis B e antigen; hepatitis B surface antigen; hepatitis B virus; nonalcoholic fatty liver.
© 2019 Wiley Periodicals, Inc.
References
REFERENCES
-
- World Health Organization. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization; 2015.
-
- Han SH, Tran TT. Management of chronic hepatitis B: an overview of practice guidelines for primary care providers. J Am Board Fam Med. 2015;28:822-837.
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73-84.
-
- Bzowej NH. Nonalcoholic steatohepatitis: the new frontier for liver transplantation. Curr Opin Organ Transplant. 2018;23:169-174.
-
- Chan AWH, Wong GLH, Chan HY, et al. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. J Gastroenterol Hepatol. 2017;32:667-676.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous